Menu Back to Global-Labeling-2014-Compliance-in-a-Changing-Regulatory-Environment

Program Committee

  • Steven W. Bass, PhD
    Steven W. Bass, PhD President Bass Biopharm Consulting Group LLC, United States
  • Su-Yueh  Lin, MS, RPh
    Su-Yueh Lin, MS, RPh Sr. Director, Head of Regulatory Labeling Regeneron Pharmaceuticals Inc, United States
  • Bruce  Boulton, MSc
    Bruce Boulton, MSc Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases Health Canada, Canada
  • Mark A. Collins, PhD, MBA
    Mark A. Collins, PhD, MBA Senior Director, Risk Management Endo Pharmaceuticals Inc., United States
  • Barbara J. Fanelli, MS
    Barbara J. Fanelli, MS Associate Vice President, Global Regulatory Affairs Labeling Sanofi , United States
  • A. Leander  Fontaine, DrMed
    A. Leander Fontaine, DrMed President Pharmiceutics, LLC., United States
  • Rie  Matsui, RPh
    Rie Matsui, RPh Director, Regional Labeling Head for Asia International Labeling Group Pfizer Japan Inc., Japan
  • Gerrit  Nijveldt, MSc
    Gerrit Nijveldt, MSc Senior Director, Global Regulatory Affairs Labeling Sanofi US , United States
  • Barbara  Lachmann, MD
    Barbara Lachmann, MD Barbara Lachmann Labeling Consulting, Germany
  • Megann  Looker
    Megann Looker Celgene Europe Ltd., United Kingdom
  • Julie P.  Retzinger, MBA, RN
    Julie P. Retzinger, MBA, RN Director, Strategic Global Labeling Baxter Healthcare Corporation, United States
  • Junko  Sato, DrSc, PhD
    Junko Sato, DrSc, PhD International Coordination Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More